PRIMARY FOCUS

Since 2020, Remora Capital has re-focused its core investment strategy on:

  • Immunotherapy - using the patient own immune system to fight diseases

  • Oncology - the treatment of cancer 

  • Best-in-class drug candidates - with a clear medical, industrial or economic added-value  

  • New generation of biologics - more potent, cheaper or more convenient